Personalized Shared Eye-care Identification of Age-related Macular Degeneration Using Artificial Intelligence and Telemedicine by Matching Optometrist Office-based Sites With Clinical Supervision

Sponsor
Medical University of Vienna
Study ID
NCT06465212
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
55 Years - 99 Years
Healthy Volunteers
Accepted

Interventions

  • TopCon Maestro 2 OCT — DEVICE
    Ophthalmic Coherence Tomography

Study Details

Office-based optometrist centres equipped with low-cost OCT devices can be used for screening of age-related macular degeneration. Matching next-door optometrist centres with clinical sites introduces a shared care service in an unprecedented and broad manner and offers timely and inclusive access to eye care for all citizens affected by the most frequent blinding disease in western countries. The aim of the study is to detect AMD in a next-door office-based setting on an individual level using low-cost OCT, through a telemedicine feedback loop. The specific aims of this study are: * Setting up a network of optometrist centres matched to clinical sites to perform shared care to protect eyesight in the elderly population. * Identify imaging biomarkers of age-related macular degeneration from OCT imaging. * Give a risk estimation of progression using a one-time low-cost OCT scan

Key Dates

First listed
Jun 18, 2024
Start date
Jul 31, 2024
Status verified
Jun 2024
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
5,000 participants (estimated)

Primary Outcome Measure

Identification of different AMD stages on OCT images from a community-based setting to calculate the real-world prevalence of AMD [ Time Frame: 2 years ]

Central Contacts

Find similar trials

Nationwide
Age-related macular degeneration trialsOphthalmology trialsRetina trials

Related Studies